Choroideremia clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)
open to eligible people ages 18 years and up
A Phase 1, open-label, non-randomized, dose-escalation study, where approximately 15 eligible patients with retinitis pigmentosa or choroideremia will be enrolled sequentially in up to 3 dose cohorts of RTx-015. Enrolled patients will receive a…
at UC Irvine
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
Sorry, accepting new patients by invitation only
The objective of the study is to evaluate the long-term safety and efficacy of a sub-retinal injection of BIIB111 in participants with Choroideremia (CHM) who have been previously treated with BIIB111 and who have exited an antecedent study; these…
at UCLA
Last updated: